Skip to main content
Clinical Trials/KCT0006935
KCT0006935
Recruiting
未知

A multi-center randomized controlled trial comparing the safety between reduced-port and conventional laparoscopic distal gastrectomy for early gastric cancer (KLASS-12)

ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Enrollment
348
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients diagnosed with adenocarcinoma in endoscopic biopsy before surgery.
  • 2\) Patients aged 20 to 85 years old.
  • 3\) Patients with a clinical stage evaluated by preoperative endoscopy (or endoscopic ultrasound) and CT examination with T1N0M0 by 8th AJCC gastric cancer staging system
  • 4\) Laparoscopic distal gastrectomy and lymph node resection above D1\+ are scheduled, and patients who can undergo radical surgery by this procedure.
  • 5\) A patient who fully explained the purpose and contents of the test before participating in the test and signed a written consent form approved by the Institutional Research Ethics Review Committee to participate in this study according to his free will.

Exclusion Criteria

  • 1\) History of abdominal surgery including gastrectomy (excluding laparoscopic appendectomy and laparoscopic cholecystectomy)
  • 2\) If combine resection is expected (Cholecystectomy is possible)
  • 3\) A patient who received chemotherapy or radiation treatment before surgery for gastric cancer diagnosed this time.
  • 4\) Patients who underwent surgery or chemotherapy for other organ primary cancer within the last 5 years (excluding completely cured skin basal cell carcinoma and in situ cervical cancer)
  • 5\) Vulnerable subjects (those who lack medical ability, pregnant women, or those who are planning to conceive)
  • 6\) Patients who have participated in other clinical trials within the last 6 months or are currently participating

Outcomes

Primary Outcomes

Not specified

Similar Trials